>
Ivermectin & Cancer: 3 Tumor-Killing Mechanisms No Oncologist Is Talking About
Two Weeks to Flatten the Fuel Curve: Digital IDs, Rationing, Energy Austerity
9 Proven Ways to Boost Your Soil Health
This Forgotten NASA Insulation Trick Cuts AC Costs 70%. They Stopped Teaching It in 1991.
We Build and Test Microwave Blocking Panels - Invisible to Radar
Man Successfully Designs mRNA Vaccine To Treat His Dog's Cancer
Watch: Humanoid robot gets surprisingly good at tennis
Low-cost hypersonic rocket engine takes flight for US Air Force
Your WiFi Can See You. Here's How.
Decentralizing Defense: A $96 Guided Rocket Just Put Precision Warfare into the Hands of the People
Israel's Iron Beam and the laser future of missile defense
Scientists at the Harbin University of Science and Technology have pioneered a sophisticated...
Researchers have developed a breakthrough "molecular jackhammer" technique...
Human trials are underway for a drug that regrows human teeth in just 4 days.

The U.S. Food and Drug Administration just made it a lot easier for patients with hard-to-treat post-traumatic stress disorder to use MDMA, a popular rave drug, to treat their condition. Under an FDA program known as Expanded Access, 10 sites across the nation can apply for approval to administer the drug under a doctor's supervision. Just 50 patients will be enrolled, but it could open the door to wider availability of MDMA and give real-world evidence that the drug works as effectively as studiesĀ suggest.